AstraZeneca Plc (AZN) Q1 2023 Earnings Call Transcript

AZN earnings call for the period ending March 31, 2023.

Related Keywords

Japan ,Beijing ,China ,Qingdao ,Shandong ,Germany ,United States ,Chinese ,American ,James Gordon Jpmorgan ,Simon Baker Redburn ,Mark Purcell Morgan Stanley ,Imfinzi Trx ,Michael Leuchten ,Peter Welford ,Andrew Baum Citi ,Seamus Fernandez ,Peter Welford Jefferies ,Emmanuel Papadakis ,Mark Purcell ,Pulmicort Flexhaler ,Pantumor Enhertu ,Sandy Barnett ,Cristian Massacesi ,James Gordon ,Mattias Haggblom Handelsbanken ,Pascal Soriot ,Naresh Chouhan ,Andrew Baum ,Luisa Hector Berenberg ,Morgan Stanley ,Matthew Weston ,Luisa Hector ,Simon Baker ,America Merrill Lynch ,Seamus Fernandez Guggenheim ,Tim Anderson Wolfe Research Analyst ,Oncology Research ,Emmanuel Papadakis Deutsche Bank Analyst ,Novartis ,American Academy Of Neurology ,Biopharmaceuticals Research ,Cellular Biomedicine Group ,Company Analyst ,Naresh Chouhan Intron Health Analyst ,Sachin Jain Bank ,Astrazeneca Plc ,Credit Suisse ,European Commission ,Deutsche Bank ,Astrazeneca ,Motley Fool Stock Advisor ,Stock Advisor ,Aradhana Sarin ,Vice President ,American Academy ,Financial Times ,Climate Leaders ,Tim Anderson ,Mattias Haggblom ,Capital Markets ,Harbour Biomed ,James Quigley ,Michele Sample ,Wolfe Research ,Redburn Partners ,Handelsbanken Capital Markets ,Executive Vice President ,Guggenheim Partners ,